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ORIGINAL RESEARCH
Abstract: With the hypothesis that depression affects memory through a mechanism other
than that of the benzodiazepines, the present study evaluated the acute effect of diazepam
10 mg upon explicit memory in patients with major depression. A double-blind, placebo (starch
50 mg) controlled experiment was carried out with 19 patients randomly divided into diazepam
(n = 10) and placebo (n = 9) groups. They were evaluated by the Mini-Mental State Examination,
and tests were conducted for immediate and delayed (short-term) memory with emotionally
toned stimuli (negative, positive, neutral), recognition, and semantic memory in visual or
auditory modality. The Visual Analog Mood scale (VAMS) was applied to measure anxiety
and mood changes after the administration of drugs (30 minutes and 6 hours). Higher scores
in the positively toned list among patients who received diazepam were observed, at the
30-minute compared with the 6-hour evaluation. The recall index of positive words in the
diazepam group was positive and significantly different from the index of the placebo group.
No anterograde amnesia following diazepam was observed. The neural model of a dysfunction
of limbic prefrontal cortical structures that impairs the modulation of the amygdala in major
depression may explain the present results. Consequently, the action of diazepam on the
amygdala, which has been proposed to be the basis of its anxiolytic action, might be altered,
modifying the modulation of memory in our patients.
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Introduction
There is extensive evidence that benzodiazepines, the most widely prescribed
psychotropic drug class (Greenblatt et al 1983), induce anterograde amnesia in both
humans and animals (Lister 1985; Thiebot 1985). The findings of several experiments
suggest that the anxiolytic properties of benzodiazepines involve effects mediated
by the amygdala. Intra-amygdala injections of benzodiazepines produce anxiolytic
effects comparable to those induced by systemic injections (Nagy et al 1979; Scheel-
Krüger and Petersen 1982; Shibata et al 1982; Niehoff and Kuhar 1983; Petersen et
al 1985). Furthermore, intra-amygdala injections of the benzodiazepine antagonist
flumazenil attenuate the anxiolytic effects of systemically administered
benzodiazepines (Hodges et al 1987). Recent findings by Izquierdo and colleagues
(1990) suggest that benzodiazepine impairment of memory involves GABAergic
type A receptors in the amygdala. Post-training intra-amygdala injection of flumazenil
causes memory facilitation comparable to that found with systemic injections, and
systemic injection of flumazenil before training attenuates the amnestic effects of
post-training intra-amygdala injection of muscimol.
Studies examining the memory-modulating effects of drug treatments have
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amygdala GABAergic compounds. When administered
shortly after training, GABAergic agonists (eg, muscimol
and baclofen) impair memory retention, while GABAergic
antagonists (eg, picrotoxin and bicuculline) enhance
retention (Breen and McGaugh 1961; Brioni and McGaugh
1988; Brioni et al 1989; Castellano et al 1989; Ammassari-
Teule et al 1991). On the other hand, there is extensive
evidence indicating a key role for GABA neurotransmission
in the modulation of fearful/defensive behaviors. It has been
found that systemic or intra-amygdala injections of GABA
agonists reduce and GABA antagonists enhance
experimental fear and anxiety (Graeff 1990). Furthermore,
lesions of the amygdala attenuate the antianxiety as well as
the memory-modulating effects of GABAergic drugs
(Shibata et al 1989; Ammassari-Teule et al 1991). A recent
study with magnetic resonance spectroscopy revealed low
GABA levels in the occipital cortex of depressed patients,
but in vivo GABA(A)-receptor binding activity with
benzodiazepine radioligand was not altered. Cortical
benzodiazepine binding to GABA(A) receptors has been
measured with 
123I-labeled flumazenil and single photon
emission computed tomography in unmedicated patients
with major depression and healthy volunteers (Kugaya et al
2003).
Depression is currently seen as a chronic medical
disorder that produces as much functional limitation and
morbidity as chronic diseases such as hypertension and
diabetes (Angst 1999). One of the most frequent and
neuropsychologically well investigated symptoms in
depression is reduced memory capacity (Burt et al 1995;
Ilsley et al 1995). The condition is thought to result from
dysfunctions in monoaminergic systems affecting
norepinephrine, serotonin, and dopamine at several effector
sites. Disturbances of the limbic–hypothalamic–pituitary–
adrenal axis and the serotonin system were found, and
changes in adrenoceptors associated with the pituitary–
adrenal axis function strongly implicate a disorder in central
noradrenergic transmission (Leonard 2000). The effect of
corticotropin-releasing factor in modulating the activity of
noradrenergic neurons in the locus ceruleus may provide a
link between environmental trigger factors and central
noradrenergic dysfunction (Leonard 2000).
We hypothesized that depression may affect the
amygdala noradrenergic modulation of memory and,
through the noradrenergic/GABAergic connection, may
modify the anterograde amnestic effect of benzodiazepines.
Furthermore, the action of benzodiazepines may block the
negative tendency on emotional memory tasks described
for depressed patients. The purpose of the present study
was evaluation of the effect of diazepam on explicit memory
(emotional and non-emotional tasks) in patients with
major depression who were not previously receiving
benzodiazepines.
Methods
A double-blind, placebo-controlled experiment with
diazepam 10 mg (Novaquim-Sigma
®) was carried out with
DSM-IV Major Depression patients (by certificated
psychiatrists) during the first 24 hours after admission in
the psychiatric unit of a general university hospital. All
patients who fulfilled inclusion criteria during a 12-month
period entered the study. The inclusion criterion was a major
depression episode (DSM-IV). Exclusion criteria were
psychotic symptoms, other psychiatric comorbidity (eg,
alcohol and drug abuse), long-term use of benzodiazepines
(last 30 days), cognitive deficit, use of tricyclic
antidepressants, and previous ECT. Cognitive status was
checked with the Mini-Mental State Examination (Folstein
et al 1975) with cut-offs 24 and 17 for education of > 4 and
≤ 4 years, respectively (baseline Mini-Mental). During this
period, 19 patients were included (15 women, age range
25–58 years). Drug groups did not differ in age, education,
and sex distributions (Table 1).
All patients signed a written consent after the nature of
procedures and objectives of the study were explained. The
study was approved by the Research Ethics Committee.
Only patients who were not taking benzodiazepines were
selected for the study (before and after hospitalization).
Nontricyclic antidepressant drugs were not taken as a reason
for exclusion. There were no group differences (diazepam
versus placebo) in the dose or type of antidepressant being
taken. Patients who presented severe insomnia received
promethazine 25 mg, whereas anxiety was behaviorally
handled.
All patients were given either placebo (50 mg of starch)
or diazepam (10 mg) on the morning of the fourth day
Table 1 Demographic variables and baseline Mini-Mental (MM)
of the studied groups; mean and standard deviation (range)
Variable Diazepam Placebo p-value
Age (y) 37.3 ± 9.6 (25–48) 44.2 ± 8.82 (37–58) 0.796
a
Education (y) 8.9 ± 3.6 (4–15) 5.9 ± 2.8 (2–8) 0.143a
Sex (M/F) 2/8 2/7 0.667
b
MM baseline 27.11 ± 2.32 (23–30) 26.33 ± 2.74 (23–30) 0.589
a
a Student’s t-test.
b Chi-square (Fisher’s test).Neuropsychiatric Disease and Treatment 2005:1(3) 271
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(Figure 1). The drugs were given orally in enteric capsules,
and patients were assigned to the two groups by a double-
blind design. The medications were specially processed for
the experiment in the hospital pharmacy, where they were
assembled in identical capsules. Only one member of the
team carried out the randomization and kept the codes of
identification of the medications. This person was unaware
of patient results. Those who applied tests and gave
medication to patients did not know which was being
administered to each patient, and patients did not know
which medication they were receiving.
Thirty minutes and 6 hours after drug or placebo
administration, patients were exposed to an emotionally
neutral word list, and to two closely matched and
emotionally arousing lists – negative and positive (Ceitlin
et al 1995). Also administered were the Logical Memory
(subtest of the Wechsler Memory scale; a neutral short story)
(Wechsler 1973) and the non-verbal “silhouette” test (black
images of universally recognized buildings) (Rosat et al
1990). Two sets of equivalent tests (word lists, short story,
and silhouettes) were used in the study. The order of
presentation of sets was the same for the two groups. The
Mini-Mental State Examination was also administered at
the 30-minute evaluation. These tests for explicit memory
were selected because they evaluate immediate and delayed
(short-term) memory, recognition, and semantic memory
in visual or auditory modality and were well studied in the
population from which the sample was recruited.
The Brazilian Portuguese words were obtained in two
studies (Ceitlin et al 1995) for the development of
emotionally negative, positive, and neutral lists. The
emotional content of the words, effect on other words in
mixed lists, and effect of age, education, and symptoms of
depression were evaluated before the final lists were
achieved. The Portuguese idiom in Brazil still lacks
population studies on quantitative linguistics (such as word
frequency and age of acquisition). Therefore, the Ceitlin
study covered most of these factors for generation of the
present word lists.
The effect of the emotionally arousing word lists on a
patient’s subjective states (mood and anxiety) was evaluated
by the Visual Analog Mood scale (VAMS) (Norris 1971),
which consists of 16 analog items composed of two
adjectives with opposite feelings, separated by a 10-cm line
on which the subject has to mark the point which best
describes his/her feelings at the time. These items were
combined into four factors (anxiety: calm–excited, relaxed–
tense, tranquil–troubled; physical sedation: quick-witted–
mentally slow, proficient–incompetent, energetic–lethargic,
clear-headed–muzzy, gregarious–withdrawn, well
coordinated–clumsy, strong–feeble; mental sedation: alert–
drowsy, attentive–dreamy; other feelings and attitudes:
interested–bored, amicable–antagonistic, happy–sad,
contented–discontented) according to a factorial analysis
performed on a Brazilian sample (Zuardi et al 1993).
Statistical analysis
All procedures were executed by the Statistical Package for
the Social Sciences (SPSS/PC Plus) and EPI-INFO 6.4.
Parametric data were analyzed by Student’s t-test for
independent samples and by multivariate procedures of
MANOVA. Categories were tested by analysis of association
Figure 1 Study procedures and randomization. Abbreviations: MD, major depression.
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(chi-square test with Yates correction or Fisher’s exact test).
Neuropsychological scores were submitted to a pegboard
test (normal probability plot) before being analyzed by
MANOVA (either between or within effects). The univariate
analysis within the multivariate procedure was family-wise
controlled for alpha values, and two-tailed significance
values were chosen.
An index of variation (rate) for the word lists was
calculated from the recalls at 30 minutes and 6 hours, based
on the calculation for rate of forgetfulness (Isaac and Mayes
1999):
D = (xi – xii)/xi (1)
where xi is the score of recall 30 minutes after drug intake
and xii of recall at 6 hours.
This rate may enhance the effect of the intervention
because both retrievals occurred after exposure to the list
(auditory task); consequently, second recall was more likely
to be higher owing to the learning effect. In the case of a
positive index, first retrieval was higher than second,
expressing a greater effect of the drug than of practice.
Results
Performance on word lists with positive emotional content
showed a statistically significant score gradient from 30
minutes to 6 hours after drug administration only in the
group of patients who received diazepam (Figure 2). Patients
who received diazepam presented higher and more positive
indexes for positive words, while negative and neutral words
presented negative rates. Patients receiving placebo showed
negative rates for the three classes of words. Although not
statistically significant, the index negativity was lower for
negative and higher for neutral words. We observed a very
large standard deviation for recall of neutral words; however,
individual scores of this word list were all negative within
the diazepam group and both negative and positive within
the placebo group. For positive words, the gradient showed
the least variation among the diazepam group, significantly
less than in placebo patients. These findings may suggest a
facilitatory effect of diazepam (10 mg) on the recall of
positive words (30 minutes after administration). At the
6-hour evaluation, performance on the positively loaded
words decreased to a similar level to that of the placebo group.
The scores of the VAMS were not different within each
group (p > 0.05) or between groups (p > 0.05). Therefore,
the significant rate of recall for positively loaded words
among diazepam patients could not be explained by lower
levels of anxiety or other symptoms. Patients, either
diazepam or placebo, showed similar levels of symptoms at
the two time-points.
No parallel improvement on other immediate recall was
seen at 30 minutes relative to 6 hours after dosing (diazepam
group). The score of the immediate recall of the short history
at 30 minutes was lower than at 6 hours (p = 0.035) (Table 2).
There was no difference between the immediate and delayed
retrievals of this test at 30 minutes after medication
(p = 0.361). However, at the 6-hour evaluation, immediate
recall was higher than delayed (p = 0.028).
For the positive word list, the score during the effect of
diazepam was higher than 6 hours later (p = 0.043). The
neutral and the negative lists did not show similar effects
(p = 0.260 and p = 0.093, respectively).
The visual recognition task (silhouette test) showed
higher performance at 6 hours than at 30 minutes for the
immediate (p = 0.018) and delayed (p = 0.028) retrievals
(Table 2). The effect of practice was probably responsible
Figure 2 Mean and standard deviation of rate of recall of the word lists
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for this difference. However, no significant difference was
observed for the comparison of the immediate and delayed
recalls 30 minutes and 6 hours after drug intake (p = 0.139
and p = 0.234, respectively).
In the placebo group, the score of immediate recall of
the short history at 6 hours after medication was higher than
that at 30 minutes (p = 0.012), as was the delayed retrieval
(p = 0.036). There was no significant difference between the
immediate and delayed retrievals either 30 minutes or
6 hours after medication (p = 0.753 and p = 0.655,
respectively). Immediate performance in the visual
recognition task (silhouette test) after 6 hours was higher
than at the 30-minute session (p = 0.030). The comparison
of performances between immediate and delayed at 30
minutes and at 6 hours (p = 0.484 and p = 0.675, respectively)
and between the delayed recognitions (p = 0.183) showed
no statistical differences (Table 2).
Discussion
The enhancement of emotionally positive tasks in the
diazepam group relative to the placebo group may suggest
improvement of the retrieval of information by diazepam.
Improvement of retrieval by benzodiazepines has been
observed (Izquierdo and Chaves 1988; Chaves et al 1990),
and it was hypothesized that the phenomenon would not be
a true facilitation of retrieval processes, but the result of
reduced interference from items presented after drug
administration and thus a secondary consequence of drug-
induced amnesia (retroactive interference) (Loftus and
Palmer 1974; Chaves et al 1990). Because of the small
sample size and the relatively large number of comparisons
that were carried out, consideration of our results should
take these limitations into account. For that reason, selection
of the statistical techniques (analyses and alpha control) was
especially careful. Therefore, further investigation with
larger samples is mandatory. However, our results are
provocative and raise an interesting hypothesis.
Comparisons between diazepam and placebo groups
showed no difference on non-emotional memory tests.
Patients did not present anterograde amnesia following
administration of diazepam; however, this effect has been
demonstrated in normal volunteers and animals (Sutton et al
1988; Zuardi et al 1993). Benzodiazepine effects are
mediated through the GABA(A) complex by enhancing
GABA-induced synaptic inhibition. As the GABAergic
system in the amygdaloid complex is a site of action for the
anxiolytic effects of benzodiazepines, it has been suggested
that benzodiazepines may also influence memory through
the amygdala. Lesions in the amygdaloid complex can block
diazepam-induced retention deficits, and central and lateral,
but not basolateral, amygdala nuclei lesions impaired
retention (Tomaz et al 1993). The amygdala is a key structure
in the brain’s integration of emotional meaning with
perception and experience and has been implicated in the
pathophysiology of major depression (Drevets 1999;
Bremner et al 2000). There is growing interest in
understanding brain mechanisms of memory formation for
emotionally arousing events, a development closely related
to renewed interest in the concept of memory consolidation.
There is little doubt that memory for emotionally arousing
events is better than for neutral stimuli. This is clearly
adaptive, because emotional stimuli, whether pleasant or
aversive, are generally more important to species survival
(Hamann et al 1999). Most current evidence indicates that
the amygdala is not a site of storage of memory processes
but plays a key role in modulation of emotional memory for
both human (McGaugh et al 1996; Cahill and McGaugh
1998) and nonhuman subjects (Barros et al 1999; Bianchin
et al 1999). Long-term, but not short-term, memory has been
shown to be enhanced by emotional arousal (Quevedo et al
2003).
Depression may affect the amygdala noradrenergic
modulation of memory and, through the noradrenergic/
GABAergic connection, may modify the anterograde
Table 2 Mean and standard deviation (range) of scores of tests without emotional content and with immediate (I) and delayed (D)
recalls
Diazepam Placebo
Test 30 min 6 h p-value
a 30 min 6 h p-value
a
Short story I 6.77 ± 1.64 (4–10) 8.57 ± 2.00 (5–10)
b 0.035 6.66 ± 0.86 (6–8) 8.00 ± 1.120 (7–10) 0.012
Short story D 6.56 ± 1.59 (4–10) 7.44 ± 1.81 (5–10)b 0.052 6.78 ± 1.20 (5–8) 8.11 ± 1.05 (7–10) 0.036
Visual recognition I 4.22 ± 1.30 (3–6) 5.89 ± 1.53 (4–8) 0.018 3.89 ± 1.76 (1–6) 5.33 ± 1.58 (3–7) 0.030
Visual recognition D 5.22 ± 1.20 (4–7) 6.57 ± 2.06 (4–10) 0.028 4.44 ± 1.33 (3–7) 5.22 ± 0.97 (3–6) 0.183
a Within-group comparison.
b p = 0.028 (immediate > delayed recall – short story at 6 hours).Neuropsychiatric Disease and Treatment 2005:1(3) 274
Delgado et al
amnestic effect of benzodiazepines. Functional neuro-
imaging studies of the anatomical correlates of familial
major depressive disorder and bipolar disorder have
identified abnormalities of resting blood flow and glucose
metabolism in depression in the amygdala and the orbital
and medial prefrontal cortical areas that are extensively
connected with the amygdala (Drevets 1999). The amygdala
metabolism in major depression and bipolar disorder is
positively correlated with both depression severity and
stressed plasma cortisol concentrations measured during
scanning. Thus, a neural model of a dysfunction of limbic
prefrontal cortical structures impairing modulation of the
amygdala in major depression, leading to abnormal
processing of emotional stimuli, may be considered.
Consequently, the action of diazepam on the amygdala,
which has been proposed to be the basis of its anxiolytic
action, might be altered, modifying the modulation of
memory in our patients.
Substantial evidence from animal and human subject
studies converges on the view that memory for emotionally
arousing events is modulated by an endogenous memory-
modulating system consisting, at a minimum, of stress
hormones and the amygdaloid complex. Within the normal
range of emotions experienced, this system is viewed as an
evolutionarily adaptive method of creating memory strength
that is, in general, proportional to memory importance
(Cahill 1997).
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